Ultragenyx Corp (RARE): Market Value

Public company logo of ultragenyx.com (RARE)

Sales growth of approved drugs for orphan diseases creates strong momentum for Ultragenyx Pharmaceutical (RARE), although risks remain regarding the limited patient population and the complexity of insurance reimbursements. Price action on the GURU.Markets platform stands at 1.63, confirming the company's status as an exclusive provider of life-saving therapies. This lack of alternatives guarantees stable sales and high product profitability.

ultragenyx.com - RARE Market Value (period 07/04/2022 - 11/17/2026)

Ultragenyx Pharmaceutical - analytical breakdowns and key metrics (RARE)

Fundamental company analysis:Ultragenyx Pharmaceutical Inc. (RARE)
Original product of Ultragenyx Corp

The market capitalization of Ultragenyx Pharmaceutical (RARE) reflects the total value of its equity, which depends directly on market confidence in its unique team of geneticists and their achievements in rare disease therapies. The product of the current share price and the total number of outstanding shares determines the company's exchange capitalization, allowing investors to assess the scale of the business and avoid purchasing the asset at the peak of the market cycle.

Competitors of Ultragenyx Pharmaceutical

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization BEAM (Beam Tx)|Market Value Sarepta (SRPT)|Twist Bioscience - Market Capitalization|Market Capitalization TXG (10x Genomics, Inc.)|Market Capitalization Intellia Therapeutics, Inc. NTLA|STOK - Market Value|BLFS: Market Value|WVE (Wave Life Sciences) - Market Valuation|Maze Therapeutics (MAZE) - Market Capitalization|Market Value Sionna Corp|Prime Medicine Inc (PRME) - Market Capitalization|Market Value Taysha Corp (TSHA)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.